Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers compared data on more than 9,000 people with HIV who took either version of tenofovir.
That’s according to a study of 55 HIV-positive people with end-stage kidney failure.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
Advocate John Tenorio could be the first HIV-positive person to receive a kidney from a living donor with HIV.
Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Researchers urge clinicians to closely monitor their patients with HIV and chronic kidney disease.
With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.
For people living with HIV, exposure to hepatitis C virus (HCV) is linked to a higher risk of kidney disease and bone disorders.
People with HIV in British Columbia have a shorter life expectancy and spend longer living with illnesses compared with those without HIV.
A hep C cure in those with HIV is tied to a lower rate of death, AIDS-defining illnesses, advanced cirrhosis and liver cancer.
Conditions include kidney disease, diabetes and high blood pressure.
The proportion of those treated for age-related conditions will steadily rise, creating potential conflicts between treatments.
Curing hepatitis C virus (HCV) is associated with a reduced risk of death, kidney disease and diabetes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.